Inventor · disambiguated record
Melita Dvorak-Ewell
Also filed as: DVORAK-EWELL MELITA
10 granted patents·2 pending applications·74 citations·filing 2009–2025
90Inventor score
Top patents by PatentIndex Score
12 records- 0194US9834587B2Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2015·Granted Dec 5, 2017·6 cites·12 claims
- 0294US9834588B2Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2015·Granted Dec 5, 2017·7 cites·12 claims
- 0393US10301369B2Nucleic acids encoding targeted therapeutic lysosomal enzyme fusion proteinsBIOMARIN PHARM INC·Filed 2017·Granted May 28, 2019·5 cites·17 claims
- 0492US9771408B2Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2015·Granted Sep 26, 2017·4 cites·12 claims
- 0592US8128925B2Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereofVELLARD MICHEL CLAUDE·Filed 2009·Granted Mar 6, 2012·38 cites·29 claims
- 0691US9845346B2Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2015·Granted Dec 19, 2017·4 cites·12 claims
- 0791US9376480B2Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2013·Granted Jun 28, 2016·6 cites·21 claims
- 0890US11254725B2Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2019·Granted Feb 22, 2022·2 cites·13 claims
- 0989US10934534B2Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereofBIOMARIN PHARM INC·Filed 2020·Granted Mar 2, 2021·2 cites·29 claims
- 1080US2022127326A1Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses ThereofBIOMARIN PHARM INC·Filed 2022·Application pending·0 cites
- 1177US12188058B2Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereofBIOMARIN PHARM INC·Filed 2021·Granted Jan 7, 2025·0 cites·1 claims
- 1277US2025388644A1Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2025·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →